Abstract  by unknown
JACC February1997 ABSTRACTS-Poster 449A
at constantflow (10 mllmin) with a modified Krebs-Henseleit-solution. This
was followed by sequential perfusion (SP) without (group 1, n = 5) and with
(group 2, n = 5) preceding IS (10 rein) of the firat heart (HI). In group 1
no significant changes of the contractile parameters of HZ were observed
during SP. In group 2, after a global 10-min IS of HI left ventricular (LV)
systolic pressure of H2 (basal 76 * 3 mmHg, SEM) immediately decreased
by 16%, +LVdP/dt”u (1492 + 112 mmH@s)by 22%, –LVdP/dt~~ (1261 +
57 mmHgfs) by 30% when R was started. Coronary perfusion preasure (77
+ 3 cm HzO) deereased by 26%. These Parametem returned to baseline
within 10 min. The cardiodepressant effect was not influenced by protease
(chymotrypsine 0.005 U/l) or by heating the coronary effluent (CE) to 56%2
for 30 min. CE kept at room temperature for 24 hours before delivery to H2
also retained its activity. Incubation (30 rein) of the CE with free radical (FR)
scavengers (superoxide dismutase and catalase, 1 x 10-7 WI, respectively)
did riot modulate its cardiodepressant effect. These data suggest the release
of stable cardiodepressant mediators from myocardial tissue after global IS
during R. FRs are not involved in the decrease in contractile force and the
resistance against protease and heating suggest that proteins are neither
implicated.
m105533 Chronic Alcohol Use AttenuatesIschemidt?eperfueion Injury by Activation of
Adenosk!e Al snd not A2 receptors
M. Miyamae, S.A. Camacho, M.W. Weiner, V.M. Figueredo. Urriversifyof
Ca/ifOt7ria,San Francisco, CA, USA
In addition to decreasing the incidence of fatal coronary events, recent evi-
dence demonstrates that chronic alcohol use (CAU) improves survival post-
Ml. Totest the hypothesis that CAU improves survival post-Ml by attenuating
ischemiaheperfusion injury (l/R), we subjected hearts from guinea pigs fed
10%alcohol in their waterfor6 wks (CAU), and age-matched controls (CTL),
to45min ischemiaand 46 min reperfusion. Todetermine if this protection was
mediated, similar to ischemic preconditioning (PC), by activation of adeno-
sine receptors, additional hearts underwent l/R in the presence of the Al
antagonist, 8-eyclopentyi-l ,3-dipropylxanthine (200 nM), the A2 antagonist,
3,7-dimethyl-l-propargylxanthine (10 wM), or following PC. Results: After
i/R, CAU hearts had 71% higher LV developed pressure (LVP), .52~o lower
diastolic pressure (LVEDP), and a 55% less creatine kinase release (CK).
Adenoaine Al, not A2, receptor blockade abolished the protective effect of
CAU. Corona~ flow and perfusion pressure were not different in any group.
Cone/usion:Attenuation of l/R by CAU is mediated via adenosine Al and not
A2 receptors, in a manner analogous to PC.
Pre-ischemia 48 min Reperfusion
n LVP (mmHg) LVEDP (mmHg) LVP LVEDP CK (U/g.ml)
CTL tO 112+4 10*O 35+ 3 46*4 356 +26
CAU 10 116+3 10*O 60+ 2* 22 +2* 159 k 25*
CAU + Al 10 113*3 10+0 31 +4 48+5 374 +46
CAU + AZ 6 120+3 10*O 56 +5* 24 *4* 179+ 35*
Pc 6 116+4 10*O 62& 6* 26A 4“ 167+21*
(mean + SEM; lP < 0.05vs CTL)
-i Effectoflsch~mi. end Repetfue,onon
Lysoplssmalogen Accumulation in an In Vivo
Canine Model
V. Dnvik, G.D. Lopaschuk, B.1.Jugdutt, K. Strynadka, M. Khan,
P.W.Armstrong, P.M.Olley. Edmonton, Canada
Rapid activation of plaamalogen-selective phospholipase A2 (P-PLA2), pre-
viously shown during, experimental ischemia-reperfusion, likely gives t’f$e
to the accumulation of Iysoplasmalogens (LP), Iysoplasmenylcholine (LPC)
and Iysoplasmenyl-ethanolamine (LPE), believed to play a deleterious role
in ischemia-reperfusion injury While shown in iachemia and reperfusion in
isolated working hearts, accumulation of LPC and LPE in vivo has not as yet
been documented. The pupose of this study was to determine the content
of LPC and LPE in ischemic and non-ischemic myocardial tissue after 60
minutes of ischemia and again after 30 minutes of reperfusion in an in vivo
canine model of transmural ischemia. Four anaesthesized mongrel dogs un-
derwent left thoracotomy and occlusion of the mid left anterior descending
coronary artery with a snare for 60 minutes. Biopsies were obtained from
Samnla LPC [mean I SD) LPE
Nonischemiczone I + 60 631.9* 300.0 735.S +425.6
Ischemk zone I + 60 1169.7 +396.6 t552.0k425.6*
Nonischemiczone R+ 34 552.3* 104.7 636,6 *44.3
Ischamiczone R + 30 650.5 +234.0 7t5.O + 294.5
p c 0,05 ve. Nonlschemiczone I + 60 and vs. Isehemiczone R+ 30
the ischemic and non-iachemic zones at the end of the ischemic period (1+
60) and again after 30 minutes of reperfusion (R + 30). LP were measured
using two stage high performance liquid chromatography. The results of the
content of LPC and LPE in nmol/gm wet weight are summarized in the table.
Regional transmural ischemia is associated with significant accumulation
of myocardial LP, in particular LPE in the in vivo canine heart, possibly due to
the activation of P-PLA2 in this setting. In contrast to isolated working heati
models, LP levels in the in vivo canine heart return to normal by 30 minutes
after the onset of repetiusion. Pharmacological inhibition of this activation
may further clarify the importance of this mechanism.
[-[ ~tectionof ,,~o-~ef,ow,(~ones in~eperfueed
Myocardial Infarction: MR Contract Agenta veraua
a Standard Fiuorascent Tracer -
Emmanuelle Canet, Michael F.Wendland, Maythem Saeed, Fabrice Pirot,
Juerg Schwitter, Nikita Derugin, Charles B. Higgins. University of California
at San Francisco, San Francisco, CA, USA
The “no-reflow” phenomenon was first demonstrated in reperfused infarction
using the fluorescent tracer thioflavin S. The purpose of this study was to
compare tomographic regional distributions of magnetic resonance imaging
(MRI) mntrast medium and thioflavin S in a rat model of the “no-reflow” phe-
nomenon Sprague-Dawley rats subjected to coronary artery occlusion for
90 minutes and reflow for 4 hours. MR contrast agent and thioflavin S were
administrated intravenously three minutes before sacrifice. Both ex-vivo MR
imagesand 2 mm slices of the heart photographed under ultraviolet light were
compared to infarcted and reperfused hemorrhagic areas. Myocardial speci-
mens of “no-reflow” and control zones were prepared to measure thioflavin S
concentration by high performance liquid chromatography. On post-contrast
MR images, the enhanced region corresponded to the repetfusd infarcted
zone. Conversely, under ultraviolet illumination, a nonfluorescent “no-reflow”
area was evident within the infarcted zone in all hearts and corresponded
to hemorrhagic infarction on histology. However, a substantial quantify of
thioflavin S was also present in both the nonfluorescent “no-reflow” (86 ~
13% of normal myocerdium concentration) and the highly fluorescent reper-
fused regions (100.7~7.5% of normal, n = 9, p = NS). In vitro, addition of
blood to thioflavin S solutions caused a quenching of thioflavin S fluores-
cence. In conclusion, we report that thioflavin S, an agent that has long
been used to document the “no-reflow” phenomenon in various tissues, is
not specific for detection of poor perfusion and gives a false diagnosis of
“no-reflow” in presence of hemorrhage. The clinical MR contrast agent is a
more reliable indicator of reperfusion sinca its effect on MR imagee is not
vitiated by myocardial hemorrhage.
-[ OpanAt’t.tyReperfusion ProduceaDiatinct
Patterns of Myocardial Blood Flow-Glucoae
Metabolism Mismatch
D. Jagasia, C.K. Ng, P.Garg, J,M. Whiting, R. Soufer, P.H. McNulty. VA
Connecticut Medical Center and Vale University Schoo/ of Medicine, New
Haven, Cz USA
In treating acute coronary occlusion, open-artery reperfusion (OAR) maybe
superior to reperfusion through a residual stenosis. To test whether suc-
cessful OAR restores normal tissue metabolism, we performed a 20-min left
coronary occlusion followed by 24 hrs OAR in intact rats (n = 36). Ischemic
areas averaged 49 + 2% of LV volume. Two-D echo revealed regional hy-
pokinesis 6 hrs after OAR, but by 24 hrs funtiion recovered and reperfused
regions were viable by TTC staining, light and eleetron microscopy. After 24
hrs OAR, 13NH3 and 18FDG were injected IV and hearts excised, sectioned
and dual-isotope counted to compare myocardial blood flow (MBF) and glu-
cose uptake in the reperfused area to remote regions. Resu/ts: MBF was 25
+8% (epicardial) to 33 + 7% (endocardial) lower in reperfuaed than remote
regions (p < 0.05), and all sections with reduced MBF exhibited increases in
both flow-corrected (193 l61%) and absolute (82* 24%) 18FDG uptake (p
< 0.05). Three distinct MBF-metabolism patterns were seen. Sectione with
< 25% MBF reduction had 18FDGV13NH3ratios < 3.0. Those with > 500/L
MBF reduction had much higher ratios (6.6 * 2.1, p < 0.01), indicating an
exponential relationship between MBFand glucose uptake. Absolute 18FDG
uptake was also higher in reperfused sections with normal MBF, suggesting
a primaiy increaee in cellular glucose avidity. Glycogen content, however,
remained lower in reperfused than control regions (1,0*5 vs. 21 * 8 #mol/g,
p < 0.05). Conclusions: 1)OAR presetves myocardial function and viabil-
ity, but regional MBF declines over the subsequent 24 hra; 2) Glycogen is
not repleted by 24 hrs OAR, indicating that imported glucose is shunted
into glycolysis. This suggeets persistent dependence on glycolytic energy in
repetiused regions. 3) Regions treated with OAR exhibit characteristic pat-
terns of MBF-18FDG mismatch which allow them to be distinguished from
both normal and non-viable myocardium.
